Generics - AstraZeneca, Pricing

Filter

Current filters:

AstraZenecaPricing

Popular Filters

Slow-down of European bipolar therapy market set for short-term slowdown

04-07-2012

Patent expiry of key blockbuster atypical antipsychotic drugs is likely to cause a decline in growth…

AstraZenecaEuropeGenericsMarkets & MarketingNeurologicalPatentsPharmaceuticalPricingSeroquel

Cipla slashes price of generic cancer drug Nexavar in India by 76%; other cuts too

04-05-2012

Indian drugmaker Cipla (BSE: 500087) has slashed the prices of certain life-saving cancer drugs used…

Asia-PacificAstraZenecaBayerCiplaGenericsIressaMerck & CoNexavarOncologyPharmaceuticalPricingTemodar

AstraZeneca launches new Crestor savings card in USA, as generic Lipitor about to debut

07-11-2011

The US subsidiary of Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday launched a new savings…

AstraZenecaCardio-vascularCrestorGenericsLipitorNorth AmericaPfizerPharmaceuticalPricing

Back to top